Jim Cornall

biotech

New approach to rare disease drug development yields first research results

biotech

PFAS in medicines can often be replaced with alternatives

biotech

Polyomaviruses: new approaches to prevention and treatment

biotech

ten23 health obtains Swissmedic licences for Basel and Visp facilities

biotech

SK bioscience launches initiative to reduce uncertainty in vaccine-development decisions

biotech

Human embryo gene-correction research approved

biotech

New immunotherapy strategy targets aggressive brain tumours and their fuel

biotech

New tool gives scientists clearer view of DNA regulation